Document is current

Article History

Received: 3 June 2025

Accepted: 5 September 2025

First Online: 22 September 2025

Declarations

:

: Katsuyoshi Matsuoka has served as a speaker for EA Pharma, Kissei, Mitsubishi Tanabe, Takeda, Janssen, AbbVie, Pfizer, Mochida, Kyorin, Zeria, Nippon Kayaku, Gilead, Eli Lilly, and Bristol Myers Squibb, is an advisory board member for Janssen, AbbVie, Eli Lilly, Gilead, Celltrion, and Bristol Myers Squibb, and has received research funding from Mochida and AbbVie. Fumihito Hirai has served as a speaker for AbbVie, EA Pharma, Janssen, Mochida, Mitsubishi Tanabe, and Takeda, and has received research funding from AbbVie, Janssen, Eli Lilly, and MSD. Kenji Watanabe has served as a speaker for Mitsubishi Tanabe, Takeda, Mochida, EA Pharma, AbbVie, JIMRO, Kyorin, Janssen, Pfizer, and Kissei, is a consultant for EA Pharma, is a member of the Data Safety Monitoring Board for EA Pharma, is a member of the Advisory Board for Takeda, and has received research funding from EA Pharma and Takeda. Ryota Hokari has no conflicts of interest to declare. Taku Kobayashi has served as an advisory board member, consultant, or speaker for AbbVie, Alfresa Pharma, Alimentiv, Bristol Myers Squibb, Celltrion, Covidien, EA Pharma, Eli Lilly, Ferring, Galapagos, Gilead Sciences, Janssen, JIMRO, Kissei, Kyorin, Mitsubishi Tanabe, Mochida, MSD, Nippon Kayaku, Pfizer, Takeda, and Zeria, and has received research funding from AbbVie, Alfresa Pharma, Bristol Myers Squibb, EA Pharma, Gilead Sciences, Helmsley Charitable Trust, Kyorin, Miyarisan, Mochida, Nippon Kayaku, Otsuka Holdings, Pfizer, Sekisui Medical, Samsung, Takeda, Zeria, and JIMRO. Masayuki Saruta has served as a speaker for AbbVie, Janssen, Mitsubishi Tanabe, Takeda, EA Pharma, Gilead, Kissei, Mochida, Nobelpharma, and Viatris, and has received research funding from AbbVie, CMIC Corporation, Janssen, Mochida, and Zeria. Hiroshi Nakase has served as a speaker for AbbVie, Kissei, Kyorin, Mitsubishi Tanabe, Janssen, Takeda, Pfizer, EA Pharma, Mochida, Daiichi Sankyo, Gilead, Viatris, and JIMRO, is an advisory board member for Janssen and Pfizer, and has received research funding from Pentax Medical, Mitsubishi Tanabe, Mochida, AbbVie, Miyarisan, JIMRO, and Kyorin. Takahiro Suzuki is an employee of EA Pharma. Gakuto Yamazaki is an employee of Kissei. Toshifumi Hibi has served as a speaker for AbbVie, EA Pharma, JIMRO, Zeria, Mitsubishi Tanabe, Takeda, Janssen, Pfizer, and Mochida, is a consultant for Celltrion, JIMRO, AbbVie, Eli Lilly, Mitsubishi Tanabe, Mochida, Takeda, EA Pharma, and Janssen, and has received research funding from Alfresa Pharma, Kyorin, JIMRO, Zeria, Mochida, and Miyarisan. Mamoru Watanabe has served as a speaker for Mitsubishi Tanabe, Zeria, EA Pharma, Mochida, and Eli Lilly, is a consultant for EA Pharma, Kissei, Eli Lilly, and MSD, and has received research funding from Zeria, AbbVie, and Nippon Kayaku. Tadakazu Hisamatsu has served as a speaker for Mitsubishi Tanabe, Pfizer, AbbVie, EA Pharma, Janssen, and Takeda, and has received research funding from EA Pharma and Kissei.